Seetharama D Jois Selected Research

Seetharama D Jois Research Topics

Disease

18	Neoplasms (Cancer) 05/2023 - 01/2016
6	Lung Neoplasms (Lung Cancer) 05/2023 - 09/2017
3	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
2	COVID-19 01/2022 - 10/2020
2	Adenocarcinoma of Lung 01/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2017
2	Adenocarcinoma 01/2020 - 11/2019
2	Colonic Neoplasms (Colon Cancer) 11/2019 - 01/2019
1	Infections 10/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Hypercholesterolemia 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Experimental Arthritis 11/2015
1	Rheumatoid Arthritis 11/2015
1	Autoimmune Diseases (Autoimmune Disease) 11/2015

Drug/Important Bio-Agent (IBA)

8	PeptidomimeticsIBA 05/2023 - 11/2015
7	Peptides (Polypeptides)IBA 01/2022 - 01/2016
5	ErbB Receptors (EGF Receptor)IBA 01/2023 - 11/2019
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 11/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2023 - 01/2017
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2020
3	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 01/2020 - 01/2017
3	compound 18IBA 01/2020 - 09/2017
2	Liposomes (Liposome)IBA 05/2023 - 10/2021
2	LigandsIBA 05/2023 - 01/2022
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2021 - 01/2020
1	Cytotoxins (Cytolysins)IBA 05/2023
1	TrehaloseIBA 05/2023
1	Cell Surface ReceptorsIBA 01/2022
1	pyrazoloneIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	QuinazolinonesIBA 12/2021
1	Growth Factor ReceptorsIBA 02/2021
1	AntibodiesIBA 02/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2021
1	Single-Domain AntibodiesIBA 02/2021
1	Cyclic PeptidesIBA 01/2021
1	Anti-HIV Agents (AIDS Drugs)IBA 10/2020
1	Glycoproteins (Glycoprotein)IBA 10/2020
1	Antiviral Agents (Antivirals)IBA 10/2020
1	Nelfinavir (Viracept)FDA Link 10/2020
1	Olive OilIBA 06/2020
1	oleocanthalIBA 06/2020
1	Hormones (Hormone)IBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	pseurotinIBA 01/2020
1	LuciferasesIBA 01/2020
1	Contrast MediaIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	leucyl- alanyl- arginyl- leucyl- leucyl- threonineIBA 11/2019
1	MethyltransferasesIBA 01/2019
1	N-methyladenosineIBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	CeramidesIBA 01/2019
1	Codon (Codons)IBA 01/2019
1	6-methyladenineIBA 01/2019
1	RNA Precursors (Precursor, mRNA)IBA 01/2019
1	Mutant Proteins (Protein, Mutant)IBA 01/2019
1	Amino Acids FDA Link 02/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017
1	AnthracyclinesIBA 01/2017
1	mesoporphyrin IXIBA 01/2016

Therapy/Procedure

5	Therapeutics 01/2023 - 09/2017
1	Drug Therapy (Chemotherapy) 05/2023
1	Ligation 10/2022
1	Precision Medicine 02/2021
1	Immunotherapy 01/2020
1	Intravenous Administration 11/2019
1	Immunomodulation 11/2015